Hyphema and vitreous hemorrhage after micropulse cyclophotocoagulation a case report

Abstract

Introduction

We present two cases of vitreous hemorrhage after micropulse cyclophotocoagulation one of which had concurrent hyphema. To the best of our knowledge, these are the first cases of vitreous hemorrhage due to micropulse CPC in the United States.

Case description

The first case is an 82-year-old woman with bilateral severe primary open angle glaucoma. BCVA in the right eye was 20/25, and 10-2 Humphrey visual field showed severe peripheral defects. The patient underwent MPCPC of the right eye and at one week, a settled 2 mm hyphema and vitreous hemorrhage confirmed by B-scan were noted. At three months, the patient had a BCVA of 20/80 with an IOP of 12 and retina consultation deferred a PPV. The second case is of a patient with bilateral moderate stage POAG who underwent MPCPC in both eyes. His original VA was 20/200 bilaterally. At 2 weeks, RE VA was count fingers at one foot and LE was 20/150-1. At two months, a RE B scan revealed dense vitreous opacities. Retina consultation revealed vitreous hemorrhage but a PPV was deferred.

Conclusion

Clinicians should be aware of the risks of bleeding and the potential need for additional surgical interventions after MPCPC.

Keywords

GLAUCOMA ciliary body ablation procedures < GLAUCOMA open angle glaucoma < GLAUCOMA postoperative posterior segment / vitreous problems < LENS / CATARACT postoperative anterior segment problems < LENS / CATARACT

Get full access to this article

View all access options for this article.

References

SWY

Wong

JKW

. Micropulse laser for the treatment of glaucoma: a literature review. Surv Ophthalmol 2019; 64: 486–497. DOI: https://doi.org/10.1016/j.survophthal.2019.01.001

Sanchez

Peirano-Bonomi

Grippo

. Micropulse transscleral cyclophotocoagulation: a hypothesis for the ideal parameters. Med Hypothesis Discov Innov Ophthalmol 2018; 7: 94–100.

Williams

Moster

Rahmatnejad

, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma 2018; 27: 445–449. DOI: https://doi.org/10.1097/ijg.0000000000000934

Chamard

Bachouchi

Daien

, et al. Efficacy, safety, and retreatment benefit of micropulse transscleral cyclophotocoagulation in glaucoma. J Glaucoma 2021; 30: 781–788. DOI: https://doi.org/10.1097/ijg.0000000000001900

Prager

Anchala

. Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy. Am J Ophthalmol Case Rep 2020; 18: 100659. DOI: https://doi.org/10.1016/j.ajoc.2020.100659

Aldaas

Brasington

Zhang

. A case of choroidal and vitreous hemorrhage following micropulse transscleral cyclophotocoagulation. J Glaucoma 2020; 29: e57–e59. DOI: https://doi.org/10.1097/ijg.0000000000001529

Emanuel

Grover

Fellman

, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma 2017; 26: 726–729. DOI: https://doi.org/10.1097/ijg.0000000000000715

Dhanireddy

Yin

Dosakayala

, et al. Severe inflammation and hyphema after micropulse diode transscleral cyclophotocoagulation. J Glaucoma 2020; 29: e50–e52. DOI: https://doi.org/10.1097/ijg.0000000000001508

Wang

Cheang

Hwang

, et al. Vitreous haemorrhage: a population-based study of the incidence and risk factors in Taiwan. Int J Ophthalmol 2017; 10: 461–466. DOI: https://doi.org/10.18240/ijo.2017.03.21

10.

Zemba

Camburu

. Uveitis-Glaucoma-Hyphaema syndrome. General Review. Rom J Ophthalmol 2017; 61: 11–17. DOI:https://doi.org/10.22336/rjo.2017.3